Skip to main content
. Author manuscript; available in PMC: 2010 Dec 6.
Published in final edited form as: Clin Transplant. 1990 Apr;4(2):63–67.

Table 4.

Current status of the surviving patients

Patient Number Latest Postop. Liver Function Insulin or Enzyme Replacement Weight Early Satiety and/or Pain with meals Number of Meals per day Stools/day Follow-up (days)


Bilirubin (mg%) Albumin (mg%) Protime (sec) Preop Lowest Now ≤ 6 months Postop. > 6 months Postop. ≤ 6 months Postop. > 6 months Postop. ≤ 6 months Postop. > 6 months Postop.
2 0.9 4.2 11.2 0 109 95 95 only with big meals no 6 3–5 1* 0–1* 416
4 0.2 3.6 11.3 0 140 112 125 no no 6 3 2* 1–2 364
5 1.0 4.5 12.4 0 159 137 122 occasionally no 6 3–5 3–4* 1* 325
7 0.5 4.0 12.7 0 141 99 99 no no 6 3–5 2–3* 2–3* 296
8 0.4 4.1 11.8 0 140 95 124 yes no 6 3 3* 3* 290
10 0.5 4.0 11.5 0 168 126 126 occasionally no 6 3–4 3* 3* 247
13 0.6 3.8 12.0 0 121 110 110 no 6 4* 205
14 0.8 3.1 10.6 0 120 83 86 yes 3 3* 202
15 0.5 3.9 12.7 0 145 90 98 only with big meals 6 2–3* 177
*

Treatment for diarrhea (with dypnoxylate HCL (patients 2, 5, 14, 15) loperamide HCL (patients 7, 10) propantheline bromide (patient 8) and atropine (patient 13)).